Americas Small Cap Research Summary

This report provides research summaries and target price updates for Americas small-cap companies including Monopar Therapeutics, Visteon Corp, and Shoals Technologies.

Key Takeaways

• 1.Monopar Therapeutics shows continued neurologic improvement in Phase 3 FoCus trial, supporting mid-year NDA filing.
• 2.Visteon Corp management meeting highlights growth conservatism and strategy to mitigate inflationary headwinds through productivity and market expansion.
• 3.Shoals Technologies is past the margin trough with resilient core solar demand despite near-term headwinds.

Table of Contents

• Summary of Changes
• Company Research
• Publications Summary

Document Preview

Page 1 of 5

Subscribe for full accessStart Free Trial